On January 16, 2018 MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), reported that MediciNova has accepted an invitation to present at the 98th Annual Meeting of the Chemical Society of Japan to be held in Funabashi-city, Chiba in Japan (Press release, MediciNova, JAN 16, 2018, View Source;p=RssLanding&cat=news&id=2326908 [SID1234523151]). The presentation entitled "Drug Repositioning: An Experience at MediciNova" will be presented by Yuichi Iwaki, MD, PhD, President and CEO of MediciNova, Inc.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

Session Date and Time: March 21, 2018, 3:00 – 3:30 pm.

Session Title: Advanced Technology Program

Location: Nihon University, Funabashi City, Chiba, Japan